跳转至内容
Merck
CN

S0652

Sucrose octasulfate–aluminum complex

别名:

Sucralfate

登录 查看组织和合同定价。

选择尺寸

关于此项目

化学文摘社编号:
54182-58-0
PubChem Substance ID:
329824435
UNSPSC Code:
12352201
NACRES:
NA.25
EC Number:
259-018-4

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

JTZPPHUZZDKEOC-RBQAPOGLSA-A

InChI

1S/C11H20O35S8.16Al.40H2O/c12-47(13,14)36-1-3-4(41-49(18,19)20)5(42-50(21,22)23)6(43-51(24,25)26)9(38-3)39-11(2-37-48(15,16)17)8(45-53(30,31)32)7(44-52(27,28)29)10(40-11)46-54(33,34)35;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h3-10H,1-2H2,(H,12,13,14)(H,15,16,17)(H,18,19,20)(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)(H,33,34,35);;;;;;;;;;;;;;;;;40*1H2/q;16*+3;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-48/t3-,4-,5+,6-,7+,8+,9+,10-,11-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1......................................................../s1

SMILES string

O[Al+]O.O[Al+]O.O[Al+]O.O[Al+]O.O[Al+]O.O[Al+]O.O[Al+]O.O[Al+]O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.[O-]S(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS([O-])(=O)=O)O[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@@H]2OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@@H]1OS([O-])(=O)=O

form

powder

impurities

<0.5% chloride content

color

white to almost white

storage temp.

2-8°C

Quality Level

200

Gene Information

human ... PGA5(5222)

正在寻找类似产品? 访问 产品对比指南

相关类别

Biochem/physiol Actions

An alkaline aluminum−sucrose complex which inhibits peptic hydrolysis and raises gastric pH.

Analysis Note

Minimum 30% sucrose octasulfate (HPLC)

Other Notes

To gain a comprehensive understanding of our extensive range of Disaccharides for your research, we encourage you to visit our Carbohydrates Category page.

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000447216
0000447216
0000386319
0000381904
0000381904

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Mitsuhiro Fujishiro et al.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 25 Suppl 1, 86-93 (2013-02-02)
Gastric endoscopic submucosal dissection (ESD) causes artificial gastric ulcers and there is no consensus regarding the optimal perioperative management in terms of prevention of intra- or postoperative bleeding and promotion of healing. Traditionally, 8-week administration of proton pump inhibitors (PPI)
Waleed Alhazzani et al.
Polskie Archiwum Medycyny Wewnetrznej, 122(3), 107-114 (2012-02-23)
Critically ill patients are at risk of developing stress ulcers in the upper digestive tract. Multiple risk factors have been associated with the development of this condition, with variable risk of association. Decades of research have suggested the benefit of
Ricky W McCullough
Medical hypotheses, 80(3), 230-233 (2012-12-26)
Irritable bowel syndrome (IBS), non-erosive reflux disorder (NERD), and functional dyspepsia (FD) are best classified as immuno-neuronal disorders of the mucosa or functional mucosal syndromes (FMS). Each appears to be clinically reversible using high potency sucralfate (HPS). In FMS of
Can sucralfate be effective to protect on peritoneal membrane in patients receiving peritoneal dialysis treatment?
Erim Gulcan et al.
Medical hypotheses, 78(3), 415-415 (2012-01-10)
V P Nelamangala Ramakrishnaiah et al.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 14(7), 876-882 (2012-02-24)
Chronic radiation proctitis with bleeding is a common problem encountered following radiotherapy for pelvic malignancy. Sucralfate-steroid enema and formalin dab are two common nonsurgical treatments. A randomized trial was conducted to compare the efficacy of these two methods. This was
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持